相关实验视频
Updated: May 10, 2026

06:51
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
30.6K
在胰腺癌中,KRAS引起的PDIA6阻断了PERK依赖的免疫细胞死亡
Liwei Zhao1,2, Peng Liu1,2, Guido Kroemer1,2,3
1Institut Universitaire de France, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Equipe Labellisée Par La Ligue Contre Le Cancer, Université Paris Cité, Paris, France.
Oncoimmunology
|March 9, 2026
概括
具有KRAS突变的胰腺癌抵抗免疫治疗. 研究人员发现PDIA6阻断免疫细胞死亡,导致免疫排除. 抑制PDIA6可能会恢复T细胞免疫力,并改善PDAC中的免疫治疗反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- KRAS突变胰腺管道腺癌 (PDAC) 对免疫检查点封锁表现出抵抗力.
- 了解抗药性机制对于改善PDAC治疗结果至关重要.
研究的目的:
- 为了确定在KRAS突变PDAC中克服免疫排除的新目标.
- 研究PDIA6在调节免疫细胞死亡和T细胞免疫中的作用.
主要方法:
- 利用分子生物学技术研究PDAC中的PDIA6功能.
- 评估PDIA6抑制对PERK依赖细胞死亡和免疫细胞透的影响.
主要成果:
- 确定PDIA6是一种KRAS驱动的PERK依赖免疫细胞死亡的抑制剂.
- 证实PDIA6抑制可以恢复CD8+T细胞免疫力.
- 抑制PDIA6对免疫治疗敏感的PDAC.
结论:
- 在KRAS突变PDAC中,PDIA6代表了一个可向的抵抗机制.
- 向PDIA6有可能提高胰腺癌的免疫疗法疗效.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

